Abstract
Microorganisms remain unrivalled in their ability to produce bioactive small molecules for drug development. However, the core technologies used to discover microbial natural products have not evolved significantly over the past several decades, resulting in a shortage of new drug leads. Advances in DNA-sequencing and bioinformatics technologies now make it possible to rapidly identify the clusters of genes that encode bioactive compounds and to make computer predictions of chemical structure based on gene sequence information. These structure predictions can be used to identify new chemical entities and provide important physicochemical “handles” that guide compound purification and structure confirmation. Industrialization of this process provides a model for improving the efficiency of natural-product discovery. The application of advanced genomics and bioinformatics technologies is now poised to revolutionize natural-product discovery and lead a renaissance of interest in microorganisms as a source of bioactive compounds for drug development.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bentley SD, Chater KF, Cerdeno-Tarraga AM, et al. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 2002;417:141–147.
Omura S, Ikeda H, Ishikawa J, et al. Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites. Proc Natl Acad Sci USA 2001;98:12,215–12,220.
Zazopoulos E, Huang K, Staffa A, et al. A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat Biotechnol 2003;21:187–190.
Miyamura S, Ogasawara N, Otsuka H, et al. Antibiotic No. 5879, a new water-soluble antibiotic against Gram-negative bacteria. J Antibiotics 1972;25:610–612.
Miyamura S, Ogasawara N, Otsuka H, et al. Antibiotic 5879 produced by Streptomyces aizunensis, identical with bicyclomycin. J Antibiotics 1973;26:479–484.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Farnet, C.M., Zazopoulos, E. (2005). Improving Drug Discovery From Microorganisms. In: Zhang, L., Demain, A.L. (eds) Natural Products. Humana Press. https://doi.org/10.1007/978-1-59259-976-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-59259-976-9_5
Publisher Name: Humana Press
Print ISBN: 978-1-58829-383-1
Online ISBN: 978-1-59259-976-9
eBook Packages: MedicineMedicine (R0)